SCHEMBL5772019

SCHEMBL5772019

Cc1nc(C2=CNCC2)c2nc(-c3cccc(Cl)c3)cc-2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 2/20 0.39
TGFBR2 P37173 2/20 0.39
HTR2C P28335 2/20 0.38
MGAM O43451 1/20 0.38
GAA P10253 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
ADORA3 P0DMS8 1/20 0.36
CDC7 O00311 1/20 0.36
MAPKAPK2 P49137 1/20 0.35
NPY5R Q15761 1/20 0.35
HTR7 P34969 2/20 0.34
SCN2A Q99250 1/20 0.34
PDGFRB P09619 1/20 0.34
KIT P10721 1/20 0.34
KDR P35968 1/20 0.34
IDO1 P14902 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5777028 0.98 HTR2C (0.38) TGFBR1TGFBR2HTR2CMGAMGAA
SCHEMBL5772801 0.85 KMO (0.36) NPY5R
SCHEMBL5772104 0.84 XDH (0.41) HTR2CCDC7NPY5RSCN2AIDO1
Hydrochloric Acid SCHEMBL5778148 0.83 KMO (0.34) NPY5R
Hydrochloric Acid SCHEMBL5774377 0.82 HTR2C (0.41) HTR2CCDC7NPY5RSCN2AIDO1
SCHEMBL5773678 0.80 RAD51 (0.36) HTR2CMGAMGAASIMGAM2
SCHEMBL5773374 0.79 MGAM (0.45) TGFBR1TGFBR2MGAMGAASI
Hydrochloric Acid SCHEMBL5773419 0.78 RAD51 (0.34) HTR2CMAPKAPK2
SCHEMBL5774961 0.77 MGAM (0.43) TGFBR1TGFBR2MGAMGAASI
SCHEMBL5772845 0.74 NPY5R (0.41) TGFBR1TGFBR2MGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP claimed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US claimed